Evolution of brain-derived neurotrophic factor levels after autologous hematopietic stem cell transplantation in multiple sclerosis
- 27 May 2005
- journal article
- clinical trial
- Published by Elsevier in Neuroscience Letters
- Vol. 380 (1-2) , 122-126
- https://doi.org/10.1016/j.neulet.2005.01.032
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Changes of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) after autologous hematopoietic stem cell transplantation in multiple sclerosisJournal of Neuroimmunology, 2004
- Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MSNeurology, 2004
- Brain-derived neurotrophic factor in patients with multiple sclerosisPublished by Elsevier ,2002
- BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?Brain, 2002
- Brain‐Derived Neurotrophic Factor, Neurotrophin‐3, and Neurotrophin‐4/5 Prevent the Death of Striatal Projection Neurons in a Rodent Model of Huntington's DiseaseJournal of Neurochemistry, 2000
- The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosisJournal of Neuroimmunology, 2000
- Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?The Journal of Experimental Medicine, 1999
- Purification and Identification of Brain-Derived Neurotrophic Factor from Human SerumProtein Expression and Purification, 1995
- Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culturePublished by Elsevier ,1990
- Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complexCell, 1982